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Cell cultures were nuttated from eptphyseal cartrlages, dtaphyseal penosteum, and muscle of 16-week human fetuses Total RNAs tsolated from 
these cultures were analyzed for the levels of mRNAs for major fibnllar collagens, two proteoglycan core protems and osteonectm In standard 
monolayer cultures the dtfferenttated chondrocyte phenotype was replaced by a dedtfferenttated one the mRNA levels of carttlage-specrfic type 
II collagen decreased upon subculturmg, whtle those of types I and III collagen, and the core proteins Increased When the cells were transferred 
to grow m agarose, redtfferenttatton (reappearance of type II collagen mRNA) occurred Ftbroblasts grown from penosteum and muscle were 
found to contam mRNAs for types I and III collagen and proteoglycan cores When these cells were transferred to agarose they acquired a shape 
mdtstmgutshable from chondrocytes, but no type II collagen mRNA was observed 
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1. INTRODUCTION 
Differentiation of mesenchymal cells into chon- 
drocytes during chondrogenesis and fracture healing in- 
volves major changes in their gene expression: a new set 
of genetically distinct collagens and proteoglycans is 
produced into the extracellular matrix (ECM) [l]. 
Studies on matrix production by cultured chondrocytes 
have demonstrated a remarkable lability of their 
phenotype: in monolayer culture, chondrocytes dedif- 
ferentiate and reduce the production of cartilage- 
specific macromolecules, type II collagen and chon- 
droitin sulfate (ChS) proteoglycan, and start producing 
type I and type III collagens [2]. Interestingly the dedif- 
ferentiated cells can be reverted to reexpress the dif- 
ferentiated phenotype by modulating culture 
conditions [3,4]. 
tion of various ECM macromolecules. Furthermore 
cells with potential chondrogenic capacity were analyz- 
ed similarly for possible cell shape-related changes in 
their gene expression. 
2. MATERIALS AND METHODS 
2.1 Cell cultures 
Standard monolayer cultures and cultures in agarose were 
established from eptphyseal cartilages, draphyseal penosteum, and 
muscle of ldweek human fetuses. The growth medmm was Dulbec- 
co’s modified Eagle medmm (DMEM) contannng 10% fetal calf 
serum. Cultures m agarose were set up as described earher [3] 
2.2. RNA extractron and Northern analysrs 
Little is known of the regulation of collagen gene ex- 
pression during these phenotypic changes. Studies with 
cultured chick chondrocytes have revealed discrepan- 
cies between transcription rates, mRNA levels and pro- 
duction of type I collagen chains, and thus suggest an 
important role for posttranscriptional control [5,6]. 
The biological significance of these observations re- 
mains unknown since chondrocytes do not contain type 
I collagen mRNA in vivo except during the very early 
stages of chondrogenesis [7-91. In the present study 
human epiphyseal chondrocytes cultured under dedif- 
ferentiating and redifferentiating conditions were 
analyzed at mRNA level for phenotype-related regula- 
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Total RNAs were extracted from cultured cells using guamdme 
tsothtocyanate [lo]. For Northern analysts total cellular RNAs 
(12 5 pg) were denatured with glyoxal, fractronated on 0 7S(rlo 
agarose gels, transferred to nylon membranes (PALL Btodyne) and 
hybridized usmg standard techniques [ll]. The following cDNA 
clones for human procollagen mRNAs were used as hybndtzatton 
probes pHCALlU (670 bp) [12] and pHCAL2 (1180 bp) [13] for the 
carboxy-propeptide domams of human procul(1) and proru2(1) 
mRNAs, respectively, pHCAR3 (1470 bp) [14] for the 3’-end of 
prool(I1) mRNA, and pHFS3 (720 bp) 1151 for the carboxy- 
propepttde domain of prool(II1) mRNA The other cDNA clones us- 
ed as probes were clone 2B-1 (1825 bp) for human ftbroblast-specific 
ChS proteoglycans core protein [16], 5E (2000 bp) for the human der- 
matan sulphate (DS) proteoglycan (PC-II, PG40) core protein [17], 
and pHon 164 (550 bp) for human osteonectm [18] The DNAs were 
labelled by the random prtmmg technique to a spectftc actrvtty of ap- 
prox 1 x 10’ cpm/pg. The filters were washed four times wtth 2 x 
SSUO 1% SDS for 5 mm at room temperature and twice with 0 1 x 
SSC/O 1% SDS for 30 mm at 55-58°C (for procollagen probes) or 
at 45-48°C (for the other probes) Dependmg on the hybndtzatton 
signal the filters were exposed with Kodak X-Omat films for 2-10 
days. 
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Fig 1. Changes m procollagen and osteonectm mRNA levels during 
dedlfferentlatlon and redlfferentlatlon of chondrocytes m culture 
For Northern analysis total RNA was isolated from eplphyseal 
cartilages (lane l), from chondrocytes m monolayer cultures m 
passage one (2), three (3), and five (4), from flbroblasts cultured from 
fetal muscle (5) and perlosteum (6), from chondrocytes m passage 
one cultured m agarose (7 and 8), from chondrocytes transferred to 
agarose after five passages m monolayer (9), and from calvanal bone 
(10). RNA samples were hybridized with cDNA probes for procYl(I) 
collagen (panel A), procu2(1) collagen (B), procul(I1) collagen (C), 
procul(III) collagen (D), and osteonectm (E) The exposure times 
were two days (panels A and B), one day (panel C), or five days 
(panels D and E) The positions of the 28 S rRNA (arrows) and 18 S 
rRNA (open arrows) are shown on the right 
3. RESULTS 
Chondrocyte dedifferentiation was readily ac- 
complished by culturing freshly isolated epiphyseal 
chondrocytes in monolayer cultures: a gradual change 
in morphology from round and cubordal cells into 
fibroblast-like cells by the fifth subculture was observ- 
ed. Northern analysis of total RNAs isolated from 
freshly isolated epiphyseal chondrocytes and from cells 
m the first, third, and fifth subculture revealed gradual 
disappearance of the mRNA for type II procollagen, 
and a concomitant increase in mRNAs for types I and 
III procollagen (fig. 1, lanes l-4). The dedifferentiation 
could be inhibited by culturing the cells in agarose 
(lanes 7 and 8). When dedifferentiated chondrocytes 
(grown in monolayer for 5 passages) were transferred 
to agarose cultures they reexpressed the original 
phenotype as shown by the reappearance of type II col- 
lagen mRNA and marked reduction of mRNAs for 
types I and III collagens (lane 9). 
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Fig 2 Changes m proteoglycan core protem mRNA levels durmg dedlfferentlatlon of chondrocytes m culture Total RNAs were Isolated from 
eplphyseal cartdages (lane l), from chondrocytes m monolayer cultures m passage one (2), three (3), and five (4), from flbroblasts cultured from 
fetal muscle (5) and perlosteum (6), and from calvarlal bone (7). Ahquots were fractionated on agarose gels, transferred to nylon membranes 
and hybrlQzed with cDNA probes for core protem of the large fibroblast ChS proteoglycan (panel A) and core protem for the small DS 
proteoglycan (B) The exposure times were ten days (panel A) or five days (panel B) The positions of the 28 S rRNA (arrows) and 18 S rRNA 
(open arrows) are shown The additional molecular size markers used are the 4 8 kb and 5 8 kb proal(1) collagen mRNAs 
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Northern analysis of periosteal and muscle 
fibroblasts grown in monolayer revealed high levels of 
type I and type III collagen mRNAs in both cell types 
(fig.1, lanes 5 and 6). In attempts to induce a chon- 
drocytic phenotype these cells were transferred into 
agarose and treated with 5- 15 ng/ml of TGF-P in the 
medium as suggested by an earlier study [ 191. This 
caused the cells to acquire a round shape, but no type 
II collagen mRNA was observed. 
Dedifferentiating chondrocytes were also analyzed 
for changes in mRNA levels of 3 other ECM com- 
ponents. The three mRNA species for the fibroblast- 
specific ChS proteoglycan core gradually appeared dur- 
ing chondrocyte dedifferentiation (fig.2, panel A). 
These mRNAs were also present in periosteal and mus- 
cle fibroblasts, but not in epiphyseal chondrocytes. The 
levels of mRNAs for DS proteoglycan core were highest 
in dedifferentiating chondrocytes (panel B). Con- 
siderably lower levels were seen in fibroblasts and 
epiphyseal chondrocytes. Osteonectin mRNA was 
observed in all samples, with the highest levels in mus- 
cle and periosteal fibroblasts (fig. 1, panel E). 
4. DISCUSSION 
A completely new pattern of collagens and other 
ECM macromolecules is expressed when mesenchymal 
cells differentiate into chondrocytes [11. Several in vivo 
studies have shown that these changes are correlated 
with the appearance and disappearance of the specific 
mRNAs coding for these molecules [7-91. In cell 
culture, chondrocytes readily dedifferentiate, but can 
also be induced to redifferentiate with concomitant 
changes in ECM production [3,4]. The present study 
demonstrates, using human epiphyseal chondrocytes 
and procollagen cDNA probes, association of the 
cartilage-specific type II collagen mRNA with the dif- 
ferentiated phenotype, and type I and type III collagen 
mRNAs with the dedifferentiated (fibroblastic) 
phenotype. This is in good correlation with the in vivo 
results, and with protein chemical data with cultured 
rabbit chondrocytes, where the change in morphology 
has previously been associated with reduction in type II 
collagen, and increase in types I and III collagen pro- 
duction [3,4]. 
Studies with chick chondrocytes have given partially 
contradictory results: presence of (modified or un- 
processed) type I collagen mRNAs suggests post- 
transcriptional regulation of collagen production [5,6]. 
Our results suggest hat most of the regulation occurs 
at transcriptional evel. How much these differences are 
dependent on the origin of chondrocytes (avran vs 
mammalian) and on the culture conditions remains to 
be shown. 
The expression patterns of the mRNAs for the other 
ECM macromolecules also exhibited some dependency 
on the phenotype. The mRNA for the (fibroblast- 
specific) ChS proteoglycan core was coexpressed with 
type I and type III collagen mRNAs. The diffuse band 
migrating at 28 S rRNA resembles that seen earlier [16] 
and may represent degraded RNA. Although the 
mRNA for the small DS proteoglycan was present in all 
cell types studied highest levels were associated with 
dedifferentiating chondrocytes. Production of os- 
teonectin by osteoblasts and hypertrophic chondrocytes 
has suggested that this molecule plays a role in the 
mineralization process [18,20]. In the present study os- 
teonectin mRNA was detected in all the cultures, with 
the highest levels in rapidly dividing fibroblasts. This is 
in accordance with suggestions that osteonectin (or 
SPARC) has also other roles in extracellular matrices 
WI. 
Research on cartilage diseases would greatly benefit 
from systems enabling differentiation of chondrocytes 
from progenitor cells in cell culture. We have shown 
that human chondrocytes propagated under dedifferen- 
tiating conditions can redifferentiate and express 
cartilage-specific mRNAs at levels comparable to in 
vivo situations. Although periosteal and mesenchymal 
fibroblasts exhibit chondrogenic potential in vivo, at- 
tempts to induce expression of the cartilage-specific 
type II collagen gene in these cells in culture failed. 
Recently growth factors associated with cartilage in- 
duction have been characterized by molecular cloning 
[19,22]. In the future it should be possible to find the 
correct combination of growth factors and culture con- 
ditions capable of supporting and inducing the chon- 
drocyte phenotype in culture, and thus to obtain 
sufficient quantities of (re)differentiated chondrocytes 
for analysis of cartilage-specific macromolecules and 
their mRNAs. 
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